Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as cisplatin, ifosfamide, and paclitaxel, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor
cells. Colony-stimulating factors, such as pegfilgrastim, may increase the number of immune
cells found in bone marrow or peripheral blood and may help the immune system recover from
the side effects of chemotherapy.
PURPOSE: This phase II trial is studying the side effects and how well giving combination
chemotherapy together with pegfilgrastim works in treating patients with previously untreated
germ cell tumors.